Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19

Last updated: March 12, 2025
Sponsor: POCHIWU
Overall Status: Active - Recruiting

Phase

N/A

Condition

Covid-19

Treatment

QI-GONG and control

Clinical Study ID

NCT06879925
CTH-113-3-5-030
NTUNHS
  • Ages 20-100
  • All Genders

Study Summary

The goal of this clinical trial is to determine whether Qi-Gong can improve physiological function and quality of life (QoL) in individuals with post-acute sequelae of SARS-CoV-2 infection (PASC).

Study Objectives:

To assess whether Qi-Gong improves physiological function in individuals with PASC.

To evaluate whether Qi-Gong enhances quality of life in individuals with PASC.

Study Design:

If a comparison group is included, researchers will compare Qi-Gong with standard care to assess its effectiveness.

Participant Involvement:

Practice Qi-Gong three times per week for three months. Record physiological data monthly.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • PASC

  • above 20 y/o

Exclusion

Exclusion Criteria:

  • Those who cannot cooperate

  • Severe schizophrenia

Study Design

Total Participants: 80
Treatment Group(s): 1
Primary Treatment: QI-GONG and control
Phase:
Study Start date:
December 02, 2024
Estimated Completion Date:
April 07, 2025

Connect with a study center

  • Renhe nursing home

    New Taipei City,
    Taiwan

    Active - Recruiting

  • Fuxi nursing home

    Taipei,
    Taiwan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.